RANA Respiratory Care Group Revenue and Competitors
Estimated Revenue & Valuation
- RANA Respiratory Care Group's estimated annual revenue is currently $140.7M per year.
- RANA Respiratory Care Group's estimated revenue per employee is $337,500
Employee Data
- RANA Respiratory Care Group has 417 Employees.
RANA Respiratory Care Group's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President & CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Director, National Initiatives | Reveal Email/Phone |
4 | Director | Reveal Email/Phone |
5 | Director, Marketing & Business Development | Reveal Email/Phone |
6 | Manager manitoba home oxygen program | Reveal Email/Phone |
7 | Senior Manager - Alberta Home Oxygen & Pulmonary Function | Reveal Email/Phone |
8 | Manager | Reveal Email/Phone |
9 | Manager, Sleep | Reveal Email/Phone |
10 | Clinic Liaison | Reveal Email/Phone |
RANA Respiratory Care Group Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2143.5M | 8506 | N/A | N/A | N/A |
What Is RANA Respiratory Care Group?
Careica Health's community-based healthcare programs have been providing care to people with respiratory disorders for over 30 years in BC, AB, SK, and MB.
keywords:N/AN/A
Total Funding
417
Number of Employees
$140.7M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
RANA Respiratory Care Group News
2022-04-17 - Barriers to and strategies to address COVID-19 testing ...
Finally, the third category relates to receiving adequate care and ... resulting in this group not seeking testing or care when needed [22].
2022-03-30 - Against COVID?19 vaccination of healthy children ...
The restriction of AstraZeneca vaccines to older age groups due to ... in the best position to provide such children with medical care).
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $188.4M | 427 | 4% | N/A |
#2 | $119.4M | 434 | 19% | N/A |
#3 | $149.5M | 443 | 27% | N/A |
#4 | $163.5M | 451 | 9% | N/A |
#5 | $142.5M | 456 | 1% | N/A |
